top of page
Magnolia tree
Screenshot 2025-03-06 at 2_edited.png

Recovery

Listen. Heal. Grow.

Image by Nick de Partee

Medication-Assisted Treatment

As part of your recovery journey, medication-assisted treatment (MAT) can play a critical role in supporting long-term success. At Magnolia Psychiatry Group, we offer Suboxone, Vivitrol, and Sublocade; three FDA-approved medications designed to reduce cravings, prevent relapse, and help you regain control of your life.

Image by Tim Mossholder
Image by Maddy Hunt

Suboxone® (buprenorphine/naloxone)

Suboxone is a combination of buprenorphine, a partial opioid agonist, and naloxone, an opioid antagonist. Buprenorphine reduces withdrawal symptoms and cravings without producing a full opioid high. Naloxone is included to deter misuse.

​

How it works:

  • Buprenorphine attaches to opioid receptors in the brain, blocking other opioids while easing withdrawal and cravings.

  • Naloxone has no effect when Suboxone is taken as prescribed, but it can trigger withdrawal if the medication is misused (e.g., injected).

  • ​

How it’s taken:
Suboxone is taken daily under the tongue (sublingually) or inside the cheek (buccally) as a film or tablet.

​

Patient Education:

  • You must be in mild to moderate withdrawal before starting to avoid precipitated withdrawal.

  • Do not eat, drink, or smoke for 15–30 minutes before or after taking the medication.

  • Store it safely away from children and pets.

  • Do not stop abruptly—always follow tapering instructions from your provider.

  • Can be used long-term depending on your recovery needs.

Image by Tim Mossholder
Image by Maddy Hunt

Vivitrol® (naltrexone extended-release injection)

Vivitrol is a monthly injection of extended-release naltrexone, a non-addictive opioid antagonist that blocks the effects of opioids.

​

How it works:
Naltrexone binds to opioid receptors and blocks euphoric and sedative effects of opioids. This helps prevent relapse by removing the “reward” of opioid use.

​

How it’s given:
Vivitrol is administered as a once-monthly intramuscular injection (usually in the buttock).

​

Patient Education:

  • You must be fully detoxed from opioids for at least 7–14 days before starting to avoid sudden withdrawal.

  • Common side effects include injection site pain, nausea, headache, and fatigue.

  • Vivitrol is not a controlled substance and has no abuse potential.

  • It also reduces alcohol cravings and may help with co-occurring alcohol use disorder.

Image by Tim Mossholder
Image by Maddy Hunt

Sublocade® (buprenorphine extended-release injection)

Sublocade is a monthly injection of extended-release buprenorphine used to treat moderate to severe opioid use disorder.

​

How it works:
Sublocade delivers a steady dose of buprenorphine over one month, reducing cravings and withdrawal while blocking other opioids.

​

How it’s given:
It is administered once a month as a subcutaneous injection (just under the skin of the abdomen) by a healthcare provider.

​

Patient Education:

  • You must be stabilized on oral buprenorphine (e.g., Suboxone) for at least 7 days before starting Sublocade.

  • It forms a small bump under the skin that gradually dissolves over the month.

  • Do not massage or touch the injection site.

  • This is a great option if you want less frequent dosing and more consistent coverage.

Image by Tim Mossholder
Image by Maddy Hunt

Brixadi® (buprenorphine long-acting injection)

Brixadi is a long-acting injectable form of buprenorphine, a partial opioid agonist used to treat opioid use disorder. It helps reduce cravings and withdrawal symptoms without producing the intense euphoria associated with full opioid agonists.

​

How it works:
Buprenorphine in Brixadi attaches to opioid receptors in the brain, blocking other opioids and easing withdrawal while reducing cravings. Its long-acting formulation provides steady medication levels, supporting recovery with fewer dosing fluctuations and no daily pill requirement.

​

How it’s taken:
Brixadi is administered as a weekly or monthly subcutaneous injection (just under the skin) by a healthcare provider. Dosing is individualized based on your treatment plan and response.

​

Patient Education:

  • You must be stabilized on buprenorphine before transitioning to Brixadi.

  • Do not attempt to self-administer; injections must be given in a clinic setting.

  • Avoid manipulating or touching the injection site.

  • Common side effects may include mild injection site pain or redness.

  • Provides continuous medication coverage to support adherence and recovery goals.

  • Can be used long-term depending on your individualized treatment plan.

Image by Tim Mossholder
Image by Nick de Partee

Which medication is right for you?

The choice between Suboxone, Vivitrol, and Sublocade depends on:

  • Your treatment goals

  • History of opioid use

  • Other medical conditions

  • Preference for daily vs. monthly dosing

  • Readiness for full detox (required for Vivitrol)

  • ​

Our team will work with you to find the best fit for your individual needs.

Image by Tim Mossholder
Image by Annie Spratt

Your recovery is our priority.

Medication is just one part of a comprehensive recovery plan. We also recommend:

​

  • Behavioral therapy or counseling

  • Regular follow-up appointments

  • Peer support groups

  • Holistic support (nutrition, housing, job assistance)

 

If you're ready to take the next step or have questions about treatment options, contact us today to schedule your confidential consultation.

Address

740 Avignon Drive, Suite C

Ridgeland, MS 39157

​

304 Enterprise Drive, Suite C Oxford, MS 38655

Phone

Main - 601.937.4552

Fax - 844.374.4872

Email

Magnolia.Psychiatry.MS@ gmail.com

Hours

Monday - Friday

8am until 4:30pm

bottom of page